0001567619-21-020867.txt : 20211119 0001567619-21-020867.hdr.sgml : 20211119 20211119172021 ACCESSION NUMBER: 0001567619-21-020867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jooss Karin CENTRAL INDEX KEY: 0001754280 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 211429386 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone bio, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Gritstone Oncology, Inc. DATE OF NAME CHANGE: 20151023 4 1 doc1.xml FORM 4 X0306 4 2021-01-07 0 0001656634 Gritstone bio, Inc. GRTS 0001754280 Jooss Karin C/O GRITSTONE BIO, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2021-01-07 4 A 0 27900 0 A 349784 D Represents Restricted Stock Units ("RSUs") which vest in two equal annual installments over a two year period measured from the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Includes 27,900 RSUs which are subject to vesting. Executive Vice President and Chief Scientific Officer /s/ Rahsaan Thompson, Attorney-in-Fact for Karin Jooss 2021-11-19